Skip to main content

Arnau Hervera Abad

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Arnau Hervera Abad

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

INHIBICION DE LA HDAC3 COMO TERAPIA PARA LESIONES MEDULARES Y ENFERMEDADES AUTOIMMUNES DEMIELINIZANTES

IP: Arnau Hervera Abad
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 66612.39
Reference: PID2020-119769RA-I00
Duration: 01/01/2023 - 31/08/2024

Ministerio de Ciencia

x

IP: Xavier Montalban Gairín
Collaborators: Arnau Hervera Abad, Miriam Izquierdo Sans
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 236350
Reference: RYC2021-033528-I
Duration: 01/01/2023 - 31/12/2027

Ministerio de Ciencia

Related news

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The Barcelona Risk Score is a flexible, generalisable clinical tool that will play a key role in selecting the most effective treatment for each person with multiple sclerosis

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Related professionals

Irene Hernández Hernández

Irene Hernández Hernández

Predoctoral researcher
Diabetes and Metabolism
Read more
Susana Núñez Pereira

Susana Núñez Pereira

Main researcher
Spine Research Unit
Read more
Leire Sanchez Corujo

Leire Sanchez Corujo

Predoctoral researcher
General Surgery
Read more
Carmen Roncal Mancho

Carmen Roncal Mancho

Postdoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.